The condition referred to as “cold tumor” allows tumor cells to more successfully escape detection and attacks from the immune system, which clarifies the observation that patients exhibiting high levels of TRMT112 expression tend to have less favorable outcomes with immunotherapy. The gene discussed is TRMT112; the disease is neoplasm.